These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10713512)

  • 1. Structure of FKBP12.6 in complex with rapamycin.
    Deivanayagam CC; Carson M; Thotakura A; Narayana SV; Chodavarapu RS
    Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):266-71. PubMed ID: 10713512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined structure of the FKBP12-rapamycin-FRB ternary complex at 2.2 A resolution.
    Liang J; Choi J; Clardy J
    Acta Crystallogr D Biol Crystallogr; 1999 Apr; 55(Pt 4):736-44. PubMed ID: 10089303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three amino acid residues determine selective binding of FK506-binding protein 12.6 to the cardiac ryanodine receptor.
    Xin HB; Rogers K; Qi Y; Kanematsu T; Fleischer S
    J Biol Chem; 1999 May; 274(22):15315-9. PubMed ID: 10336416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional visualization of FKBP12.6 binding to an open conformation of cardiac ryanodine receptor.
    Sharma MR; Jeyakumar LH; Fleischer S; Wagenknecht T
    Biophys J; 2006 Jan; 90(1):164-72. PubMed ID: 16214874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of a plant FKBP12 that does not mediate action of FK506 and rapamycin.
    Xu Q; Liang S; Kudla J; Luan S
    Plant J; 1998 Aug; 15(4):511-9. PubMed ID: 9753776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor).
    Masumiya H; Wang R; Zhang J; Xiao B; Chen SR
    J Biol Chem; 2003 Feb; 278(6):3786-92. PubMed ID: 12446682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A phosphorylation at serine-2808 of the cardiac Ca2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6).
    Xiao B; Sutherland C; Walsh MP; Chen SR
    Circ Res; 2004 Mar; 94(4):487-95. PubMed ID: 14715536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energetic and structural analysis of the role of tryptophan 59 in FKBP12.
    Fulton KF; Jackson SE; Buckle AM
    Biochemistry; 2003 Mar; 42(8):2364-72. PubMed ID: 12600203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression.
    Vilella-Bach M; Nuzzi P; Fang Y; Chen J
    J Biol Chem; 1999 Feb; 274(7):4266-72. PubMed ID: 9933627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the Legionella pneumophila Mip-rapamycin complex.
    Ceymann A; Horstmann M; Ehses P; Schweimer K; Paschke AK; Steinert M; Faber C
    BMC Struct Biol; 2008 Mar; 8():17. PubMed ID: 18366641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 and FKBP12 bind to IP3 and ryanodine receptors at overlapping sites: the complexity of protein-protein interactions for channel regulation.
    Vervliet T; Parys JB; Bultynck G
    Biochem Soc Trans; 2015 Jun; 43(3):396-404. PubMed ID: 26009182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP.
    Choi J; Chen J; Schreiber SL; Clardy J
    Science; 1996 Jul; 273(5272):239-42. PubMed ID: 8662507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.
    Cruz MC; Cavallo LM; Görlach JM; Cox G; Perfect JR; Cardenas ME; Heitman J
    Mol Cell Biol; 1999 Jun; 19(6):4101-12. PubMed ID: 10330150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.
    Luengo JI; Yamashita DS; Dunnington D; Beck AK; Rozamus LW; Yen HK; Bossard MJ; Levy MA; Hand A; Newman-Tarr T
    Chem Biol; 1995 Jul; 2(7):471-81. PubMed ID: 9383449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central domain of the human cardiac muscle ryanodine receptor does not mediate interaction with FKBP12.6.
    Zissimopoulos S; Lai FA
    Cell Biochem Biophys; 2005; 43(2):203-19. PubMed ID: 16049346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of calstabin2 (FKBP12.6)-ryanodine receptor interactions: rescue of heart failure by calstabin2 in mice.
    Huang F; Shan J; Reiken S; Wehrens XH; Marks AR
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3456-61. PubMed ID: 16481613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12.
    Huse M; Chen YG; Massagué J; Kuriyan J
    Cell; 1999 Feb; 96(3):425-36. PubMed ID: 10025408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and inhibition of skeletal RyR channels by a part of the skeletal DHPR II-III loop: effects of DHPR Ser687 and FKBP12.
    Dulhunty AF; Laver DR; Gallant EM; Casarotto MG; Pace SM; Curtis S
    Biophys J; 1999 Jul; 77(1):189-203. PubMed ID: 10388749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophilins: beyond immunosuppression.
    Hamilton GS; Steiner JP
    J Med Chem; 1998 Dec; 41(26):5119-43. PubMed ID: 9857082
    [No Abstract]   [Full Text] [Related]  

  • 20. FKBPs facilitate the termination of spontaneous Ca2+ release in wild-type RyR2 but not CPVT mutant RyR2.
    Zhang JZ; Waddell HM; Wu E; Dholakia J; Okolo CA; McLay JC; Jones PP
    Biochem J; 2016 Jul; 473(14):2049-60. PubMed ID: 27154203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.